Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alvocidib and Cisplatin in Advanced Ovarian Cancer
NCT00083122Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2004
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of alvocidib in ovarian epithelial cancer, primary peritoneal cancer (PPC), sponsored by National Cancer Institute. Started Apr 2004; status: completed.
02
Drugs
alvocidib
03
Conditions
ovarian epithelial cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00083122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00083122.